Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 609, S96-S97 (2022)
doi: https://doi.org/10.1038/d41586-022-02876-5
This article is part of Nature Outlook: Psychedelic medicine, an editorially independent supplement produced with the financial support of third parties. About this content.
Updates & Corrections
-
Correction 07 October 2022: An earlier version of this Outlook article gave the wrong time frame for Vince Polito’s planned 250-participant trial.
References
Polito, V & Stevenson, R. J. PLoS ONE 14, e0211023 (2019).
Lea, T. et al. J. Psychact. Drugs 52, 101–112 (2020).
de Wit, H. et al. Addict. Biol. 27, e13143 (2022).
Szigeti, B. et al. eLife 10, e62878 (2021).